CS207392B2 - Method of making the new oxothia compounds - Google Patents

Method of making the new oxothia compounds Download PDF

Info

Publication number
CS207392B2
CS207392B2 CS772337A CS233777A CS207392B2 CS 207392 B2 CS207392 B2 CS 207392B2 CS 772337 A CS772337 A CS 772337A CS 233777 A CS233777 A CS 233777A CS 207392 B2 CS207392 B2 CS 207392B2
Authority
CS
Czechoslovakia
Prior art keywords
group
dihydro
oxo
benzo
carbon atoms
Prior art date
Application number
CS772337A
Other languages
Czech (cs)
English (en)
Inventor
Raymond Bernasconi
Pier G Ferrini
Richard Goeschke
Jacques Gosteli
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH453876A external-priority patent/CH630082A5/de
Priority claimed from CH1599476A external-priority patent/CH629797A5/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of CS207392B2 publication Critical patent/CS207392B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CS772337A 1976-04-09 1977-04-07 Method of making the new oxothia compounds CS207392B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH453876A CH630082A5 (de) 1976-04-09 1976-04-09 Verfahren zur herstellung von oxothiaverbindungen.
CH1599476A CH629797A5 (en) 1976-12-20 1976-12-20 Process for the preparation of salts of oxothia compounds

Publications (1)

Publication Number Publication Date
CS207392B2 true CS207392B2 (en) 1981-07-31

Family

ID=25695718

Family Applications (4)

Application Number Title Priority Date Filing Date
CS772337A CS207394B2 (en) 1976-04-09 1977-04-07 Method of making the new oxothia compounds
CS772337A CS207392B2 (en) 1976-04-09 1977-04-07 Method of making the new oxothia compounds
CS772337A CS207393B2 (en) 1976-04-09 1977-04-07 Method of making the new oxothia compounds
CS772337A CS207395B2 (en) 1976-04-09 1977-04-07 Method of making the new oxothia compounds

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CS772337A CS207394B2 (en) 1976-04-09 1977-04-07 Method of making the new oxothia compounds

Family Applications After (2)

Application Number Title Priority Date Filing Date
CS772337A CS207393B2 (en) 1976-04-09 1977-04-07 Method of making the new oxothia compounds
CS772337A CS207395B2 (en) 1976-04-09 1977-04-07 Method of making the new oxothia compounds

Country Status (27)

Country Link
US (1) US4320138A (fi)
JP (1) JPS52125158A (fi)
AR (3) AR218869A1 (fi)
AT (1) AT357148B (fi)
CA (1) CA1112248A (fi)
CS (4) CS207394B2 (fi)
CY (1) CY1138A (fi)
DD (1) DD130659A5 (fi)
DE (1) DE2713584C2 (fi)
DK (1) DK152046C (fi)
ES (1) ES457528A1 (fi)
FI (1) FI69461C (fi)
FR (1) FR2347363A1 (fi)
GB (1) GB1544339A (fi)
GR (1) GR70652B (fi)
HK (1) HK6182A (fi)
HU (1) HU180438B (fi)
IE (1) IE44987B1 (fi)
IL (1) IL51847A (fi)
KE (1) KE3185A (fi)
MY (1) MY8200244A (fi)
NL (1) NL7703802A (fi)
NO (1) NO146810C (fi)
NZ (1) NZ183747A (fi)
PL (3) PL110653B1 (fi)
SE (1) SE432930B (fi)
SU (4) SU795475A3 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634840A5 (de) * 1978-06-29 1983-02-28 Ciba Geigy Ag 2-oxo-2,3-dihydro-benzo(b)thiophen-verbindung und daraus hergestellte pharmazeutische praeparate.
AT392787B (de) * 1978-06-29 1991-06-10 Ciba Geigy Ag Verfahren zur herstellung des neuen n-(2-thienyl)-2-oxo-2,3-dihydro-benzo(b)thiophen-3-carboxamids

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3413308A (en) * 1966-09-02 1968-11-26 Dow Chemical Co Substituted benzo(b)thiophene-2-carboxanilides
US3655693A (en) * 1969-06-25 1972-04-11 Merck & Co Inc Anti-inflammatory salicyclic acid derivatives
US3676463A (en) * 1970-10-15 1972-07-11 Pfizer Oxobenzofuran carboxamides
US3971814A (en) * 1972-11-27 1976-07-27 Warner-Lambert Company Benzo(b)thiophene derivatives
GB1571847A (en) * 1974-01-02 1980-07-23 Systems Eng & Mfg Waste water treatment

Also Published As

Publication number Publication date
IE44987B1 (en) 1982-06-02
CY1138A (en) 1982-05-07
DD130659A5 (de) 1978-04-19
SE7704033L (sv) 1977-10-10
ES457528A1 (es) 1978-08-16
FI69461B (fi) 1985-10-31
NZ183747A (en) 1979-01-11
IL51847A (en) 1981-09-13
IE44987L (en) 1977-10-09
NL7703802A (nl) 1977-10-11
DK152046C (da) 1988-07-18
HU180438B (en) 1983-03-28
GR70652B (fi) 1982-12-03
PL111456B1 (en) 1980-08-30
PL110653B1 (en) 1980-07-31
SU898956A3 (ru) 1982-01-15
CS207395B2 (en) 1981-07-31
ATA248577A (de) 1979-11-15
PL111459B1 (en) 1980-08-30
SU795475A3 (ru) 1981-01-07
AR218869A1 (es) 1980-07-15
SE432930B (sv) 1984-04-30
CS207393B2 (en) 1981-07-31
JPS52125158A (en) 1977-10-20
CA1112248A (en) 1981-11-10
NO146810B (no) 1982-09-06
HK6182A (en) 1982-02-19
CS207394B2 (en) 1981-07-31
AR224614A1 (es) 1981-12-30
PL197311A1 (pl) 1978-01-16
FR2347363A1 (fr) 1977-11-04
DE2713584A1 (de) 1977-10-20
JPS6218556B2 (fi) 1987-04-23
FI771044A (fi) 1977-10-10
SU791239A3 (ru) 1980-12-23
DK152046B (da) 1988-01-25
IL51847A0 (en) 1977-06-30
GB1544339A (en) 1979-04-19
AR225401A1 (es) 1982-03-31
FI69461C (fi) 1986-02-10
DE2713584C2 (de) 1986-09-04
SU738510A3 (ru) 1980-05-30
FR2347363B1 (fi) 1979-03-09
US4320138A (en) 1982-03-16
DK158777A (da) 1977-10-10
MY8200244A (en) 1982-12-31
NO146810C (no) 1982-12-15
KE3185A (en) 1982-04-02
NO771231L (no) 1977-10-11
AT357148B (de) 1980-06-25

Similar Documents

Publication Publication Date Title
US4690930A (en) Pyrazolo[4,3-c]quinoline-3-one and imidazo[4,3-c]cinnolin-3-one derivatives and their use as psychotropic agents
US3362962A (en) Certain benzothiazepine derivatives
US4320133A (en) Penicillins and their antibacterial use
JPS6089469A (ja) アルド−スリダクテ−ス抑制剤としてのスピロ三環式芳香族スクシンイミド誘導体及びこれを用いた治療方法並びに薬剤組成物
AU596869B2 (en) 2-(thio-linked)-pyridine-5-(4,5-dihydro-2-oxazolyl)-(thieno( 2,3-d)-imidazoles and -benzimidazoles), a process for their preparation, and their use
CS207392B2 (en) Method of making the new oxothia compounds
CA2016182C (en) Heterocyclicguanidines as 5ht- antagonists
US3859237A (en) Quinazoline derivatives
US4260779A (en) Oxothia compounds
US4090020A (en) Thienothiazine derivatives
US4396621A (en) Certain 2-oxo-2,3-dihydro-3-benzothiophene-carboxamides and their pharmaceutical compositions
JPH0256478A (ja) ２，３，４，５―テトラヒドロ―１―ベンズオキセピン―３，５―ジオン誘導体及びその製法
CA1125761A (en) Process for the manufacture of novel oxothia compounds
US4840953A (en) 9-(Substituted thio)-4H-pyrido[1,2,-A]pyrimidin-4-one derivatives
US3291824A (en) Nu-(2-halo-lower alkanoyl) anthranilic acid derivatives
Lindley et al. Competitive cyclisation of singlet and triplet nitrenes. Part 6. The cyclisation of 2-azidophenyl thienyl sulphides
SU453840A3 (fi)
Walls et al. 11. Potential trypanocides of the N-heterocyclic series. Part II. Analogues of dimidium bromide
GB1577743A (en) Benzodiazepine derivatives
KR900006992B1 (ko) 티에닐티아졸 화합물의 제조방법
KR850000430B1 (ko) 6-치환 피라논 화합물의 제조방법
NO156483B (no) Lukkekapsel for flaske med flytende medisin
CH638204A5 (en) Process for preparing oxothia compounds
NO760614L (no) Thiazinderivater.
JPH04257584A (ja) ５，１１−ジヒドロ−６Ｈ−ジピリド〔３，２−ｂ：２′，３′−ｅ〕〔１，４〕ジアゼピンおよび該化合物を含有するＨＩＶ感染の予防又は治療用組成物